Man Group’s Immunomedics Inc IMMU Stock Holding History

Man Group’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-310,752	Closed	-$26.4M	–	2018
2020 Q3	$26.4M	Buy	310,752 +112,320	+57%	+$5.68M	0.1%	213
2020 Q2	$7.03M	Buy	198,432 +177,774	+861%	+$5.2M	0.04%	507
2020 Q1	$279K	Buy	+20,658	New	+$348K	﹤0.01%	1401
2019 Q2	–	Sell	-63,974	Closed	-$1.23M	–	2080
2019 Q1	$1.23M	Sell	63,974 -234,275	-79%	-$3.78M	﹤0.01%	1516
2018 Q4	$4.26M	Buy	298,249 +95,019	+47%	+$1.89M	0.02%	855
2018 Q3	$4.23M	Buy	203,230 +83,230	+69%	+$1.97M	0.02%	1089
2018 Q2	$2.84M	Buy	+120,000	New	+$2.41M	0.01%	1223

Man Group's IMMU Position: Q4 2020 in Review

Man Group sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 310,752 shares — an estimated $26.4M sold.

Man Group first reported a position in IMMU in Q2 2018 and held it in 7 quarters. The position peaked at $26.4M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Man Group reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Man Group sold 310,752 Immunomedics Inc shares in Q4 2020, an estimated $26.4M.
Man Group first reported a position in Immunomedics Inc in Q2 2018 and held it in 7 quarters.
Man Group's Immunomedics Inc position peaked at $26.4M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Man Group's 13F filing for Q4 2020, filed 16 Feb 2021.